BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 25800105)

  • 1. Evaluation of the current opioid misuse measure among substance use disorder treatment patients.
    Ashrafioun L; Bohnert AS; Jannausch M; Ilgen MA
    J Subst Abuse Treat; 2015 Aug; 55():15-20. PubMed ID: 25800105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying prescription opioid use disorder in primary care: diagnostic characteristics of the Current Opioid Misuse Measure (COMM).
    Meltzer EC; Rybin D; Saitz R; Samet JH; Schwartz SL; Butler SF; Liebschutz JM
    Pain; 2011 Feb; 152(2):397-402. PubMed ID: 21177035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The utility of a statewide prescription drug-monitoring database vs the Current Opioid Misuse Measure for identifying drug-aberrant behaviors in emergency department patients already on opioids.
    Wilson MP; Cucciare MA; Porter A; Chalmers CE; Mullinax S; Mancino M; Oliveto AH
    Am J Emerg Med; 2020 Mar; 38(3):503-507. PubMed ID: 31221474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the Psychometric Properties of the Current Opioid Misuse Measure Among Adults With Chronic Pain and Opioid Use.
    Rogers AH; Gallagher MW; Jamison RN; Zvolensky MJ
    Clin J Pain; 2020 Aug; 36(8):578-583. PubMed ID: 32433073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should We Use COMM (Current Opioid Misuse Measure) to Screen for Opioid Abuse in Patients With Cancer Pain?
    Moryl N; Mendoza TR; Horn SD; Eustaquio JC; Cleeland CS; Inturrisi C
    J Natl Compr Canc Netw; 2023 Nov; 21(11):1132-1140.e3. PubMed ID: 37935105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross validation of the current opioid misuse measure to monitor chronic pain patients on opioid therapy.
    Butler SF; Budman SH; Fanciullo GJ; Jamison RN
    Clin J Pain; 2010; 26(9):770-6. PubMed ID: 20842012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detecting aberrant opioid behavior in the emergency department: a prospective study using the screener and Opioid Assessment for Patients with Pain-Revised (SOAPP
    Varney SM; Perez CA; Araña AA; Carey KR; Ganem VJ; Zarzabal LA; Ramos RG; Bebarta VS
    Intern Emerg Med; 2018 Dec; 13(8):1239-1247. PubMed ID: 29502329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying the risk of opioid misuse in a chronic pain population: the utility of the MMPI-2-RF personality psychopathology five (PSY-5-RF) and higher-order scales.
    Giblin MJ; Cordaro M; Haskard-Zolnierek K; Jordan K; Bitney C; Howard K
    J Behav Med; 2022 Oct; 45(5):739-749. PubMed ID: 35913652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for current opioid misuse and associated risk factors among patients with chronic nonalcoholic pancreatitis pain.
    Barth KS; Balliet W; Pelic CM; Madan A; Malcolm R; Adams D; Morgan K; Owczarski S; Borckardt JJ
    Pain Med; 2014 Aug; 15(8):1359-64. PubMed ID: 24716629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of substance use and psychiatric disorders in a highly select chronic pain population.
    Proctor SL; Estroff TW; Empting LD; Shearer-Williams S; Hoffmann NG
    J Addict Med; 2013; 7(1):17-24. PubMed ID: 23131838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between severity of depression and prescription opioid misuse among chronic pain patients with and without anxiety: A cross-sectional study.
    Feingold D; Brill S; Goor-Aryeh I; Delayahu Y; Lev-Ran S
    J Affect Disord; 2018 Aug; 235():293-302. PubMed ID: 29660645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a Brief Version of the Current Opioid Misuse Measure (COMM): The COMM-9.
    McCaffrey SA; Black RA; Villapiano AJ; Jamison RN; Butler SF
    Pain Med; 2019 Jan; 20(1):113-118. PubMed ID: 29237039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescription opioid use among addictions treatment patients: nonmedical use for pain relief vs. other forms of nonmedical use.
    Bohnert AS; Eisenberg A; Whiteside L; Price A; McCabe SE; Ilgen MA
    Addict Behav; 2013 Mar; 38(3):1776-81. PubMed ID: 23254228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adapting the Current Opioid Misuse Measure (COMM) for people with chronic pain and disability due to arthritis: The development of the COMM 11-PWDA.
    Mallery Lankford C; Paez K; Yang M; Lin A
    Disabil Health J; 2022 Jun; 15(2S):101296. PubMed ID: 35414483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychiatric history and psychologic adjustment as risk factors for aberrant drug-related behavior among patients with chronic pain.
    Wasan AD; Butler SF; Budman SH; Benoit C; Fernandez K; Jamison RN
    Clin J Pain; 2007 May; 23(4):307-15. PubMed ID: 17449991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of the Current Opioid Misuse Measure.
    Butler SF; Budman SH; Fernandez KC; Houle B; Benoit C; Katz N; Jamison RN
    Pain; 2007 Jul; 130(1-2):144-56. PubMed ID: 17493754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spanish Validation of the COMM Scale to Assess the Misuse of Prescription Opioids in Patients with Chronic Noncancer Pain.
    Reyes-Pérez Á; López-Martínez AE; Esteve R; Ramírez-Maestre C
    Int J Ment Health Addict; 2022 Mar; ():1-15. PubMed ID: 35342377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk for prescription opioid misuse among patients with a history of substance use disorder.
    Morasco BJ; Turk DC; Donovan DM; Dobscha SK
    Drug Alcohol Depend; 2013 Jan; 127(1-3):193-9. PubMed ID: 22818513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation and comparison of tools for diagnosing problematic prescription opioid use among chronic pain patients.
    Kovatch M; Feingold D; Elkana O; Lev-Ran S
    Int J Methods Psychiatr Res; 2017 Dec; 26(4):. PubMed ID: 27774717
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.